首页|CD4+CD8-T细胞大颗粒淋巴细胞白血病的临床分析

CD4+CD8-T细胞大颗粒淋巴细胞白血病的临床分析

扫码查看
目的:探讨CD4+CD8-T细胞大颗粒淋巴细胞白血病(T-LGLL)患者的临床特征及诊疗方案.方法:报告1例CD4+CD8-T-LGLL患者的临床表现、诊断及治疗情况,并结合文献进行回顾性分析.结果:患者为老年女性(70岁),临床进展缓慢,以血小板减少为主要表现,骨髓增生较低下,血涂片以大颗粒淋巴细胞为主,免疫分型及T细胞克隆重排符合T-LGLL,应用环磷酰胺50 mg/d联合泼尼松(后逐渐减停)治疗,达到部分缓解(PR).结论:CD4+CD8-T细胞大颗粒淋巴细胞白血病临床上极为罕见,与CD4-CD8+T-LGLL临床表现存在差异.
Clinical Analysis of CD4+CD8-T-Cell Large Granular Lymphocytic Leukemia
Objective:To investigate the clinical characteristics and treatment of patients with CD4+CD8-T-cell large granular lymphocytic leukemia(T-LGLL).Methods:The clinical manifestations,diagnosis and treatment of 1 case of CD4+CD8-T-LGLL patient were reported,and relevant literatures were reviewed.Results:The patient was a 70-year-old woman with slow clinical progress,mainly manifested by thrombocytopenia and myelodysplasia.The blood smear was mainly composed of large granular lymphocytes.Immunotyping and T-cell receptor gene rearrangement analysis showed that it was in line with T-LGLL.Partial remission(PR)was achieved through the treatment of cyclophosphamide(50 mg/d)combined with prednisone(gradually reduced and stopped later).Conclusion:CD4+CD8-T-LGLL is very rare in clinical practice,and its clinical manifestations are different from those of CD4-CD8+T-LGLL.

CD4+CD8-T-cell large granular lymphocytic leukemiaclinical manifestationstreatment

常香香、孙尚彪、李玉文、王淼、朱燕青

展开 >

临泉县人民医院血液内科,安徽临泉 236400

CD4+CD8-T细胞大颗粒淋巴细胞白血病 临床表现 治疗

2024

中国实验血液学杂志
中国病理生理学会

中国实验血液学杂志

CSTPCD北大核心
影响因子:0.988
ISSN:1009-2137
年,卷(期):2024.32(5)